U.S. Wireless Telecom Stock News

Maze Therapeutics (MAZE), a clinical stage biopharmaceutical company, has drawn investor attention after recent trading. The stock last closed at $29.30 and has shown mixed returns over the past week and month. See our latest analysis for Maze Therapeutics. Looking beyond the latest move to $29.30, Maze Therapeutics has seen a 14.10% 1 month share price return and a 10.57% 3 month share price return, while its year to date share price return is down 26.33% and the 1 year total shareholder...

AMC Entertainment Holdings (AMC) opened Q2 2026 with revenue of US$1.6 billion and a loss of US$11.4 million, translating to basic EPS of a US$0.02 loss, providing a clear snapshot of where the business stands coming out of the latest quarter. The company reported quarterly revenue of US$1.40 billion in Q2 2025 and US$1.60 billion in Q2 2026, while quarterly basic EPS moved from a US$0.01 loss to a US$0.02 loss, which keeps the focus on how efficiently the larger top line is translating into...

In recent weeks, Lattice Semiconductor reported a strong first quarter with revenue and EPS growth surpassing analyst expectations, while its MachXO5-NX TDQ FPGA family earned a Gold Globee® award for first-to-market innovation in post-quantum security. Analysts have since raised earnings estimates and upgraded the stock’s rating, suggesting that Lattice’s innovation in secure, low-power FPGAs is reshaping perceptions of its long-term business strength. Now we’ll examine how this earnings...

Artificial intelligence is sitting at the center of market attention, as energy driven inflation risks, tight central bank policy and shifting trade patterns keep pressure on traditional growth stories. While oil prices, bond yields and tariff headlines move daily, AI related spending on chips, software, cloud and large language models is still a key focus for many companies and investors. This article uses an AI Stocks screener that targets businesses directly tied to the ChatGPT and broader...

Delek Logistics Partners stock has delivered strong returns over the past several years, yet the current market pricing screens as expensive on key valuation checks, leaving investors weighing a solid track record against a relatively full valuation. Over the last 5 years, Delek Logistics Partners has returned 113.2%, which puts more pressure on today’s buyers to justify the higher entry price. Future cash flow resilience and the partnership’s ability to fund its capital needs efficiently...

Andersons stock has delivered a very strong 226.3% total return over the past five years, yet the current valuation checks point to a mixed picture rather than a clear bargain or clear overvaluation at the recent price of US$77.85. A 226.3% return over five years indicates that long term holders in Andersons have been strongly rewarded, which raises the bar for new buyers assessing what is already priced in. For Andersons, the key support for valuation is whether the business can keep...

Valmont Industries (VMI) has reported another solid quarter, with Q2 2026 revenue of US$1.1 billion and basic EPS of US$6.19 supported by net income of US$119.9 million, set against trailing 12 month EPS of US$24.54 on revenue of US$4.2 billion. The company’s revenue increased from US$1.0 billion in Q1 2026 to US$1.1 billion in Q2 2026, while basic EPS rose from US$5.55 over the same period. This gives investors a fresh look at how recent earnings momentum is feeding into margins. See our...

Why KB801’s Patent Filing Matters For Krystal Biotech Stock Krystal Biotech (KRYS) recently filed a response with the U.S. Patent and Trademark Office for KB801, sharing previously undisclosed single patient data on corneal defect closure from a discontinued neurotrophic keratitis study. The company stressed that this observation comes from one patient and is not a substitute for clinical trial results. However, the disclosure offers investors a clearer view of how KB801 is progressing toward...

DHT Holdings recently secured a three-year time charter for one of its very large crude carriers with commodities major Glencore, underscoring sustained demand for its VLCC capacity in the period market. This long-duration contract not only supports operational planning and fleet employment but also enhances visibility on vessel utilization and forward revenue for the tanker owner. We’ll now examine how this multi-year Glencore VLCC charter interacts with DHT’s existing investment narrative...

Arteris (AIP) is back in focus after announcing an expanded partnership with Arm that embeds its Cycuity Radix hardware security tools more deeply into Arm’s next-generation CPU development flow. See our latest analysis for Arteris. The Arm partnership news comes after a sharp 11.54% 1 day share price return, even though the 30 day share price return is down 22.42%. At the same time, the 1 year total shareholder return of 262.50% and 3 year total shareholder return of about 3.7x highlight how...

Tariffs on imported generic drugs are set to rise sharply over the next few years, and that kind of policy shock rarely stays contained to one corner of the market. For investors, the question is which U.S. pharmaceutical and biotech manufacturing stocks might stand to benefit if production shifts closer to home, and which could face new pressures through supply chain or pricing risks. This article looks at how the new tariff path could affect larger domestic drug manufacturers and contract...

Criteo (NasdaqGS:CRTO) has drawn fresh investor attention after its recent share performance, with the stock up about 24% over the past month and roughly 11% over the past 3 months. See our latest analysis for Criteo. Despite the recent 23.68% 1 month share price return and 11.36% 3 month share price return, Criteo’s longer term picture is more mixed, with the 1 year total shareholder return declining 7.07%. This suggests improving near term momentum following weaker multi year...

JetBlue Airways stock has delivered a steep 64.2% decline over the past five years, yet on current valuation checks it still screens as cheap. This raises a clear question about whether the market is pricing in too much pessimism or the valuation metrics are missing key risks. The share price performance over five years, with a drop of 64.2%, suggests investors who held through this period have faced heavy capital losses that now frame how any apparent discount is viewed. Recent moves to...

Space Exploration Technologies (SPCX) has just been added to the Nasdaq-100 Index, bringing the recently listed stock into a widely tracked benchmark and putting its sharp post-IPO volatility in sharper focus for index investors. See our latest analysis for Space Exploration Technologies. For Space Exploration Technologies, the recent Nasdaq-100 inclusion comes after a sharp swing in sentiment, with the stock showing a 1-day share price return of 3.08% but a 30-day share price return down...

Burlington Stores (BURL) has drawn fresh attention after outlining progress with its smaller store format, updating its fiscal 2026 outlook, and planning a sizable store expansion tied to those operational trends. See our latest analysis for Burlington Stores. Those store format updates sit against a strong run in Burlington Stores’ stock, with a 7 day share price return of 6.1% and an 18.9% year to date share price return. The 3 year total shareholder return of 104.0% signals sustained...

Digital Turbine recently strengthened its mobile growth platform by launching Launchpad, a unified system to improve app discovery, and by expanding its AI capabilities through a partnership with Google Cloud, developments that were followed by an announced past-date webcast to discuss its fiscal 2027 first-quarter results. Together, these moves underscore management’s effort to deepen the company’s role in app distribution and monetization by tying on-device reach more closely to AI-driven...

Keel Infrastructure stock reacts to Sherbrooke data center and capacity shift Keel Infrastructure (KEEL) is in focus after securing Sherbrooke approval to consolidate 96 MW of existing Bitcoin mining capacity into a single campus and recategorize it for high performance computing and AI workloads. The agreement with Hydro Sherbrooke, along with a land purchase plan east of Montréal, gives Keel Infrastructure a defined path toward an HPC and AI oriented data center project, subject to...

MARA Holdings has delivered a share price decline of 54.7% over the past 5 years, yet the stock still screens as expensive on the broad valuation checks. This raises questions about how much of the high-performance computing and bitcoin policy optimism is already reflected in the current price. The 54.7% share price decline over 5 years points to a tough journey for long term holders and a need for any new bullish thesis to be very clear. Optimism around MARA Holdings repurposing bitcoin...

BGM Group (BGM) has reported FY 2025 first half revenue of about US$14.3 million and a basic EPS loss of US$0.03 per share, setting a mixed tone for investors watching the company’s momentum against a higher revenue base. The company has seen revenue move from roughly US$12.6 million in the first half of FY 2024 to US$14.3 million in the first half of FY 2025, while basic EPS shifted from a profit of US$0.06 to a loss of US$0.03. This puts the spotlight firmly on how much of that top line is...

Intuitive Surgical (NasdaqGS:ISRG) has filed for a $1.77b shelf registration tied to an employee stock ownership plan related offering. The filing creates flexibility for future issuance of shares that could be allocated to employees over time. The move may influence Intuitive Surgical's capital structure and the ownership mix between employees and other shareholders. At a share price of $350.06, Intuitive Surgical enters this ESOP linked shelf registration after a period where the stock...

Amgen stock has delivered a 75.2% return over the past five years, and the current valuation picture sits in a middle ground where the Discounted Cash Flow (DCF) intrinsic value estimate points to meaningful upside while market based multiples look roughly in line with peers. Over five years, a 75.2% total return suggests Amgen has already rewarded patient shareholders, so any further upside case now leans more on valuation support than on a low entry price. Future cash flow expectations...

In recent days, ON Semiconductor Corp. has attracted heightened attention on Zacks.com, as analysts updated earnings estimates for the current quarter and signaled expectations of earnings growth compared with the prior year. An interesting twist is that despite this upbeat earnings outlook, ON Semiconductor currently holds only a Zacks Rank #3 (Hold), implying expectations similar to the broader market rather than clear outperformance. We will now examine how these earnings growth...

Q2 2026 earnings put EQT’s recent performance in focus EQT (EQT) reported second quarter 2026 earnings that showed revenue of US$1,809.94 million and net income of US$211.43 million, figures that contrasted with stronger results in the same period last year. At the same time, EQT’s six month numbers to June 30, 2026, showed revenue of US$5,188.68 million and net income of US$1,698.65 million, setting a different tone from the quarter’s standalone snapshot. See our latest analysis for...

MGM Resorts International stock has climbed 25.2% year to date, yet its valuation checks are sending mixed signals, with the Discounted Cash Flow (DCF) intrinsic value estimate pointing to meaningful upside while earnings-based multiples lean the other way. A 25.2% gain year to date puts MGM Resorts International among the stronger consumer services stocks, which raises the bar for what counts as attractive value from here. Resilient performance at Empire City Casino, alongside investors...